Looks like you may have greater influence than you thought Pilbarapython. SP seems to have finally gained a little traction!Welcome aboard!GS
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling